Ovarian Cancer Coverage from Every Angle

NCCN Collaborative Projects in Advanced Ovarian Cancer

By: Jocelyn Solis-Moreira, MS
Posted: Tuesday, March 24, 2020

In collaboration with AstraZeneca, the National Comprehensive Cancer Network (NCCN) Oncology Research Program (ORP) has selected four ovarian cancer projects for research funding. Each project will assess a technique designed to improve the quality of care for patients with advanced ovarian cancer. The projects are expected to begin in the third quarter of 2020, with support guaranteed for 2 years.

The selected projects are the following:

  • CommunityRx-Cancer: An IT-Enhanced Patient Navigation Program for Social Determinants of Health in Advanced Ovarian Cancer: Cary Gross, MD, Yale Cancer Outcomes, Public Policy, and Effectiveness Research Center and Smilow Cancer Hospital
  • Feasibility and Impact of a Comprehensive Telehealth Program on Reducing Geographic Barriers to Treatment and Improving Symptom Management in Rural Patients With Advanced Ovarian Cancer: Haller J. Smith, MD, University of Alabama at Birmingham
  • Patient-Centered Education and Support for Women With Advanced Ovarian Cancer: Barbara Goff, MD, and Donna L. Berry, PhD, RN, AOCN, Fred Hutchinson Cancer Research Center, Seattle Cancer Care Alliance
  • REVITALIZE: A Telehealth Intervention for Women With Advanced Ovarian Cancer and PARP Inhibitor–Related Fatigue: Alexi A. Wright, MD, MPH, and Hanneke Poort, PhD (MPI), Dana-Farber Cancer Institute.

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.